Genoscience Pharma
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers (NCT05353894) | Genoscience Pharma | 2022-05-02 |
| A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection (NCT04637828) | Genoscience Pharma | 2020-11-18 |
| Study of GNS561 in Patients With Liver Cancer (NCT03316222) | Genoscience Pharma | 2018-04-04 |
Track Genoscience Pharma automatically
Every clearance here is in the API, with alerts when new ones post.